Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NUDT1 | P36639 | 5/20 | 0.43 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.39 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
| ▸ | CLK4 | Q9HAZ1 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.38 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4209540 | 0.89 | NUDT1 (0.41) | NUDT1TRPA1ATMS1PR1HSP90AA1 | |
| SCHEMBL25107058 | 0.88 | L3MBTL1 (0.55) | S1PR1HSP90AA1CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL8711626 | 0.87 | PIK3CD (0.43) | NUDT1TRPA1ATMS1PR1P2RX7 | |
| SCHEMBL125549 | 0.85 | HSP90AA1 (0.53) | NUDT1HSP90AA1CYP1A2CYP2C19TSHR | |
| SCHEMBL17125581 | 0.84 | S1PR1 (0.40) | NUDT1S1PR1HSP90AA1CYP1A2HSD17B10 | |
| SCHEMBL17125587 | 0.84 | S1PR1 (0.40) | NUDT1S1PR1HSP90AA1CYP1A2HSD17B10 | |
| SCHEMBL17125584 | 0.83 | S1PR1 (0.42) | NUDT1S1PR1MAPK1ALDH1A1NPC1 | |
| SCHEMBL17125585 | 0.83 | S1PR1 (0.42) | NUDT1S1PR1MAPK1ALDH1A1NPC1 | |
| SCHEMBL5569934 | 0.82 | GAA (0.49) | TRPA1ATMHSP90AA1TSHRMAPK1 | |
| SCHEMBL5703467 | 0.82 | GAA (0.49) | TRPA1ATMHSP90AA1TSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10240084-B2 | Non-crystallizable pi-conjugated molecular glass mixtures, charge transporting molecular glass mixtures, luminescent molecular glass mixtures, or combinations thereof for organic light emitting diodes and other organic electronics and photonics applications | MOLECULAR GLASSES, INC. (US) | 2019-03-26 | — | — | US | disclosed |
| EP-2835368-B1 | Process for Isolation of Monophenolic-Bisaryl Triazines | CYTEC TECH CORP (US) | 2017-11-15 | — | — | EP | disclosed |
| EP-2289884-B1 | Process for isolation of monophenolic bisaryl triazines | CYTEC TECH CORP (US) | 2017-09-06 | — | — | EP | disclosed |
| US-20150275076-A1 | Non-crystallizable Pi-conjugated Molecular Glass Mixtures, Charge Transporting Molecular Glass Mixtures, Luminescent Molecular Glass Mixtures, or Combinations Thereof for Organic Light Emitting Diodes and other Organic Electronics and Photonics Applications | Molaire Consulting | 2015-10-01 | — | — | US | disclosed |
| US-20150275076-A1 | Non-crystallizable Pi-conjugated Molecular Glass Mixtures, Charge Transporting Molecular Glass Mixtures, Luminescent Molecular Glass Mixtures, or Combinations Thereof for Organic Light Emitting Diodes and other Organic Electronics and Photonics Applications | Molaire Consulting | 2015-10-01 | — | — | US | disclosed |
| EP-2280005-B1 | Process for isolation of monophenolic bisaryl triazines | CYTEC TECH CORP (US) | 2015-08-26 | — | — | EP | disclosed |
| EP-2835368-A1 | Process for Isolation of Monophenolic-Bisaryl Triazines | CYTEC TECHNOLOGY CORP. (US) | 2015-02-11 | — | — | EP | disclosed |
| EP-1397352-B1 | PROCESS FOR ISOLATION OF MONOPHENOLIC-BISARYL TRIAZINES | CYTEC TECH CORP (US) | 2014-01-01 | — | — | EP | disclosed |
| EP-2289884-A1 | Process for isolation of monophenolic bisaryl triazines | CYTEC TECHNOLOGY CORP. (US) | 2011-03-02 | — | — | EP | disclosed |
| EP-2280005-A1 | Process for isolation of monophenolic bisaryl triazines | CYTEC TECHNOLOGY CORP. (US) | 2011-02-02 | — | — | EP | disclosed |
| US-6710177-B2 | REACTING A CYANURIC HALIDE WITH BENZENE COMPOUND | CYTEC TECHNOLOGY CORP. | 2004-03-23 | — | — | US | disclosed |
| EP-1397352-A2 | PROCESS FOR ISOLATION OF MONOPHENOLIC-BISARYL TRIAZINES | Cytec Technology Corp. (US) | 2004-03-17 | — | — | EP | disclosed |
| US-6632944-B2 | Such as 2-(2,4-dihydroxyphenyl)-4,6-bis(2,3-dimethylphenyl)-1,3,5-triazine via solvent extraction; for ultraviolet radiation absorption | CYTEC TECHNOLOGY CORP. | 2003-10-14 | — | — | US | disclosed |
| US-20030013879-A1 | Process for isolation of monophenolic-bisaryl triazines | CYTEC TECHNOLOGY CORP. | 2003-01-16 | — | — | US | disclosed |
| WO-2003000667-A2 | PROCESS FOR ISOLATION OF MONOPHENOLIC-BISARYL TRIAZINES | CYTEC TECHNOLOGY CORP. (US) | 2003-01-03 | — | — | WO | disclosed |
| US-6486316-B1 | Process for making triazine UV absorbers using Lewis acids and reaction promoters | CYTEC TECHNOLOGY CORP. | 2002-11-26 | — | — | US | disclosed |
| US-20020013463-A1 | Process for making triazine UV absorbers using Lewis acids and reaction promoters | CYTEC INDUSTRIES CORP. | 2002-01-31 | — | — | US | disclosed |
| EP-1131305-A1 | PROCESS FOR PREPARING TRIAZINES USING A COMBINATION OF LEWIS ACIDS WITH REACTION PROMOTERS | CYTEC TECHNOLOGY CORP. (US) | 2001-09-12 | — | — | EP | disclosed |
| US-20010020094-A1 | Process for making triazine UV absorbers using lewis acids and reaction promoters | CYTEC TECHNOLOGIES CORP. | 2001-09-06 | — | — | US | disclosed |
| WO-2000029392-A1 | PROCESS FOR PREPARING TRIAZINES USING A COMBINATION OF LEWIS ACIDS AND REACTION PROMOTERS | CYTEC TECHNOLOGY CORP. (US) | 2000-05-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020013463-A1 | Process for making triazine UV absorbers using Lewis acids and reaction promoters | TYR, TDO2, CYP4Z1 | NUDT1 238/4885TRPA1 623/4885ATM 4660/4885 |
| US-20010020094-A1 | Process for making triazine UV absorbers using lewis acids and reaction promoters | TYR, TDO2, CYP4Z1 | NUDT1 238/4885TRPA1 623/4885ATM 4660/4885 |
| US-20030013879-A1 | Process for isolation of monophenolic-bisaryl triazines | ADH1C, TET2, AHR | NUDT1 1395/4885TRPA1 2522/4885ATM 4274/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.